{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:32:15Z","timestamp":1793928735941,"version":"4.8.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cataract and neovascular age-related macular degeneration (nAMD) often co-exist and both contribute to impaired vision. It has been debated whether cataract surgery can increase nAMD activity. The purpose of this retrospective study was to investigate the impact of cataract surgery on visual acuity, treatment intensity for nAMD and macular morphology in patients with on-going treatment for nAMD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data was obtained from the Swedish Macular Register, the Swedish National Cataract Register, optical coherence tomography (OCT) images and patient charts. All eyes were treated at the Department of Ophthalmology at the County Hospital of V\u00e4stmanland, V\u00e4ster\u00e5s, Sweden. Follow-up was 6\u00a0months after surgery. The study was approved by the Swedish Ethical Review Authority.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 156 patients (168 eyes) were included. The mean age at cataract surgery was 82 (standard deviation, SD 6) years. Both distance and near visual acuity improved after surgery. Distance visual acuity increased from 59 (SD 12) to 66 (SD 15) letters ETDRS (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Proportion of eyes with normal near visual acuity increased from 12 to 41%. The anti-vascular endothelial growth factor (VEGF) treatment intensity remained unchanged: mean of 3.4 (SD 1.9) and 3.3 (SD 1.7) treatments were given 6\u00a0months pre- and postoperatively, respectively. The prevalence of intraretinal fluid (IRF) in the macula increased from 22 to 31% postoperatively, while subretinal fluid, fluid under the pigment epithelium (sub-RPE fluid) and central retinal thickness were unaltered. In eyes with new IRF, improvement in visual acuity and number of anti-VEGF treatments were similar to eyes without new IRF.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Cataract surgery improved visual acuity in patients with on-going treatment for nAMD and did not affect anti-VEGF treatment intensity. Macular morphology remained unchanged. The slight increase in intraretinal fluid after surgery was not found to affect visual acuity or anti-VEGF treatment intensity. It is hypothesized that this might indicate that it represents degenerative intraretinal cystic fluid.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-023-03028-7","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T11:02:49Z","timestamp":1686913369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cataract surgery in neovascular AMD: impact on visual acuity and disease activity"],"prefix":"10.1186","volume":"23","author":[{"given":"Hin Yan","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Ros\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3164-547X","authenticated-orcid":false,"given":"Elisabet","family":"Granstam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"key":"3028_CR1","doi-asserted-by":"publisher","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","volume":"5","author":"SR Flaxman","year":"2017","unstructured":"Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Silvester A, Stevens GA, Tahhan N, Wong TY, Taylor HR. Global causes of blindness and distance vision impairment 1990\u20132020: a systematic review and meta-analysis. Lancet Global Health. 2017;5:e1221\u201334. https:\/\/doi.org\/10.1016\/S2214-109X(17)30393-5.","journal-title":"Lancet Global Health"},{"key":"3028_CR2","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1001\/archopht.116.5.653","volume":"116","author":"CC Klaver","year":"1998","unstructured":"Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol. 1998;116:653\u20138. https:\/\/doi.org\/10.1001\/archopht.116.5.653.","journal-title":"Arch Ophthalmol"},{"key":"3028_CR3","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and metaanalysis. Lancet Global Health. 2014;2:e106-116. https:\/\/doi.org\/10.1016\/S2214-109X(13)70145-1.","journal-title":"Lancet Global Health"},{"key":"3028_CR4","first-page":"8","volume":"1135","author":"G Davis","year":"2016","unstructured":"Davis G. The Evolution of Cataract Surgery. Mo Med. 2016;1135:8\u201362.","journal-title":"Mo Med"},{"key":"3028_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ajo.2011.10.016","volume":"153","author":"SB Bloch","year":"2012","unstructured":"Bloch SB, Larsen M, Munch IC. Incidence of legal blindness from age-related mauclar degeneration in Denmark: year 2000 to 2010. Am J Ophthalmol. 2012;153:209-213.e2. https:\/\/doi.org\/10.1016\/j.ajo.2011.10.016.","journal-title":"Am J Ophthalmol"},{"key":"3028_CR6","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.ajo.2011.04.025","volume":"152","author":"PJ Rosenfeld","year":"2011","unstructured":"Rosenfeld PJ, Shapiro H, Ehrlich JS, Wong P, MARINA and ANCHOR study groups. Cataract surgery in ranibizumab-treated patients with neovascular age-related macular degeneration from the phase 3 ANCHOR and MARINA trials. Am J Ophthalmol. 2011;152:793\u20138. https:\/\/doi.org\/10.1016\/j.ajo.2011.04.025.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"3028_CR7","doi-asserted-by":"publisher","first-page":"CD006757","DOI":"10.1002\/14651858.CD006757","volume":"2","author":"H Casparis","year":"2017","unstructured":"Casparis H, Lindsley K, Kuo IC, Sikder S, Bressler NM. Surgery for cataracts in people with age-related macular degeneration. Cochrane Database Syst Rev. 2017;2(2):CD006757. https:\/\/doi.org\/10.1002\/14651858.CD006757.","journal-title":"Cochrane Database Syst Rev"},{"key":"3028_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/aos.12","volume":"93","author":"L Kessel","year":"2015","unstructured":"Kessel L, Erngaard D, Flesner P, Andresen J, Tendal B, Hjortdal J. Cataract surgery and age-related macular degeneration. An evidence-based update Acta Ophthalmol. 2015;93:593\u2013600. https:\/\/doi.org\/10.1111\/aos.12.","journal-title":"An evidence-based update Acta Ophthalmol"},{"issue":"3","key":"3028_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ajo.2015.06.006","volume":"160","author":"SS Saraf","year":"2015","unstructured":"Saraf SS, Ryu CL, Ober MD. The effects of cataract surgery on patients with wet macular degeneration. Am J Ophthalmol. 2015;160(3):487-492.e1. https:\/\/doi.org\/10.1016\/j.ajo.2015.06.006.","journal-title":"Am J Ophthalmol"},{"key":"3028_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ajo.2018.05.014","volume":"192","author":"MR Starr","year":"2018","unstructured":"Starr MR, Mahr MA, Barkmeier AJ, Iezzi R, Smith WM, Bakri SJ. Outcomes of cataract surgery in patients with exudative age-related macular degeneration and macular fluid. Am J Ophthalmol. 2018;192:91\u20137. https:\/\/doi.org\/10.1016\/j.ajo.2018.05.014.","journal-title":"Am J Ophthalmol"},{"key":"3028_CR11","doi-asserted-by":"publisher","unstructured":"Karesvuo P, Elbaz U, Achiron A, Hecht I, Kaarniranta K, Tuuminen R (2021) Effect of cataract surgery on wet age-related macular degeneration activity. Acta Ophthalmol. 10. https:\/\/doi.org\/10.1111\/aos.14864.","DOI":"10.1111\/aos.14864"},{"key":"3028_CR12","doi-asserted-by":"publisher","unstructured":"Aurell S, Sj\u00f6vall K, Paul A, Mor\u00e9n \u00c5, Granstam E. Better visual outcome at 1 year with antivascular endothelial growth factor treatment according to treat-and-extend compared to pro re nata in eyes with neovascular age-related macular degeneration. Acta Ophthalmol. 2019;97:519\u201324. https:\/\/doi.org\/10.1111\/aos.13989.","DOI":"10.1111\/aos.13989"},{"key":"3028_CR13","doi-asserted-by":"publisher","first-page":"e928","DOI":"10.1111\/aos.15025","volume":"100","author":"M Schroeder","year":"2022","unstructured":"Schroeder M, Westborg I, Fluur C, Olsen R, L\u00f6vestam-Adrian M. Exploration of real-world outcomes and treatment patterns in patients treated with anti-vascular endothelial growth factors for neovascular age-related macular degeneration in Sweden. Acta Ophthalmol. 2022;100:e928\u201335.","journal-title":"Acta Ophthalmol"},{"key":"3028_CR14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ophtha.2014.11.017","volume":"122","author":"U Schmidt-Erfurth","year":"2015","unstructured":"Schmidt-Erfurth U, Waldstein SM, Deak GG, Kundi M, Simader C. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration. Ophthalmology. 2015;122:822\u201332. https:\/\/doi.org\/10.1016\/j.ophtha.2014.11.017.","journal-title":"Ophthalmology"},{"issue":"8","key":"3028_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/aos.13120","volume":"94","author":"L Kessel","year":"2016","unstructured":"Kessel L, Koefoed Theil P, Lykke S\u00f6rensen T, Munch IC. Cataract surgery in patients with neovascular age-related macular degeneration. Acta Ophthalmol. 2016;94(8):755\u201360. https:\/\/doi.org\/10.1111\/aos.13120.","journal-title":"Acta Ophthalmol"},{"key":"3028_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ajo.2018.03.012","volume":"190","author":"Daien V, Nguyen V, Morlet N, Arnold JJ, Essex RW, Young S, Hunyor A, Gillies MC, Barthelmes D; Fight Retinal Blindness! Study Group","year":"2018","unstructured":"Daien V, Nguyen V, Morlet N, Arnold JJ, Essex RW, Young S, Hunyor A, Gillies MC, Barthelmes D; Fight Retinal Blindness! Study Group. Outcomes and predictive factors after cataract surgery in patients with neovascular age-related macular degeneration. The Fight Retinal Blindness! Project. Am J Ophthalmol. 2018;190:50\u20137. https:\/\/doi.org\/10.1016\/j.ajo.2018.03.012.","journal-title":"Am J Ophthalmol"},{"key":"3028_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1755-3768.2009.01576.x","volume":"88","author":"C Frennesson","year":"2010","unstructured":"Frennesson C, Nilsson UL, Peebo BB, Nilsson SEG. Significant improvements in near vision, reading speed, central visual field and related quality of life after ranibizumab treatment of wet age-related macular degeneration. Acta Ophthalmol. 2010;88:420\u20135. https:\/\/doi.org\/10.1111\/j.1755-3768.2009.01576.x.","journal-title":"Acta Ophthalmol"},{"key":"3028_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4274\/tjo.galenos.2018.76429","volume":"49","author":"S S\u00fcl","year":"2019","unstructured":"S\u00fcl S, Karalezli A, Karabulut M. First-year outcomes of cataract surgery combined with intravitreal ranibizumab injection in wet age-related macular degeneration. Turk J Ophthalmol. 2019;49:15\u20139. https:\/\/doi.org\/10.4274\/tjo.galenos.2018.76429.","journal-title":"Turk J Ophthalmol"},{"key":"3028_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/aos.13864","volume":"97","author":"M L\u00f6vestam Adrian","year":"2019","unstructured":"L\u00f6vestam Adrian M, Vassilev ZP, Westborg I. Baseline visual acuity as a prognostic factor for visual outcomes in patients treated with aflibercept for wet age-related macular degeneration: data from the INSIGHT study using the Swedish Macula Register. Acta Ophthalmol. 2019;97:91\u20138. https:\/\/doi.org\/10.1111\/aos.13864.","journal-title":"Acta Ophthalmol"},{"key":"3028_CR20","doi-asserted-by":"publisher","first-page":"417603","DOI":"10.1155\/2014\/417603","volume":"2014","author":"A Grixti","year":"2014","unstructured":"Grixti A, Papavasileiou E, Cortis D, Kumar BV, Prasad S. Phacoemulsification surgery in eyes with neovascular age-related macular degeneration. ISRN Ophthalmol. 2014;2014:417603. https:\/\/doi.org\/10.1155\/2014\/417603.","journal-title":"ISRN Ophthalmol"},{"key":"3028_CR21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jcrs.2011.10.036","volume":"38","author":"H Tabandeh","year":"2012","unstructured":"Tabandeh H, Chaudhry NA, Boyer DS, Kon-Jara VA, Flynn HW. Outcomes of cataract surgery in patients with neovascular age-related macular degeneration in the era of anti-vascular endothelial growth factor therapy. J Cataract Refract Surg. 2012;38:677\u201382. https:\/\/doi.org\/10.1016\/j.jcrs.2011.10.036.","journal-title":"J Cataract Refract Surg"},{"key":"3028_CR22","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.3390\/jcm10143124","volume":"10","author":"EY Choi","year":"2021","unstructured":"Choi EY, Kim TY, Lee CS. Predictive Factors for Long-Term Outcomes of Cataract Surgery in Patients Receiving Active Treatment for Neovascular Age-Related Macular Degeneration. J Clin Med. 2021;10:3124. https:\/\/doi.org\/10.3390\/jcm10143124.","journal-title":"J Clin Med"},{"key":"3028_CR23","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ophtha.2015.10.001","volume":"123","author":"Chu CJ, Johnston RL, Buscombe C, Sallam AB, Mohamed Q, Yang YC; United Kingdom Pseudophakic Macular Edema Study Group","year":"2016","unstructured":"Chu CJ, Johnston RL, Buscombe C, Sallam AB, Mohamed Q, Yang YC; United Kingdom Pseudophakic Macular Edema Study Group. Risk factors and incidence of macular edema after cataract surgery: A Database Study of 81984 Eyes. Ophthalmol. 2016;123:316\u201323. https:\/\/doi.org\/10.1016\/j.ophtha.2015.10.001.","journal-title":"Ophthalmol"},{"key":"3028_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1076\/soph.17.3.167.14794","volume":"17","author":"S Ray","year":"2002","unstructured":"Ray S, D\u2019Amico DJ. Pseudophakic cystoid macular edema. Semin Ophthalmol. 2002;17:167\u201380. https:\/\/doi.org\/10.1076\/soph.17.3.167.14794.","journal-title":"Semin Ophthalmol"},{"key":"3028_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bjophthalmol-2020-318645","volume":"0","author":"P H\u00e5rd af Segestad","year":"2021","unstructured":"H\u00e5rd af Segestad P. Risk model for intraoperative complication during cataract surgery based on data from 900\u00a0000 eyes: previous intravitreal injection is a risk factor. Br J Ophthalmol. 2021;0:1\u20137. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-318645.","journal-title":"Br J Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-023-03028-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-023-03028-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-023-03028-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T11:05:41Z","timestamp":1686913541000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-023-03028-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3028"],"URL":"https:\/\/doi.org\/10.1186\/s12886-023-03028-7","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]},"assertion":[{"value":"17 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Swedish Ethical Review Authority (Dnr 2020\u201300249; 2020\u201303-11) and adhered to the tenets of the 1964 Declaration of Helsinki and its later amendments. Each patient approved registration of medical data in the Swedish Macula Register (SMR) and additional consent for participation in the present study was not required as by the approval by the Swedish Ethical Review Authority.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the final manuscript and gave consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Author E Granstam is Advisory board member for Novartis, Bayer, Roche and Allergan and has received speaker honorarium from these companies. Authors HY Tang and M Ros\u00e9n declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"276"}}